EGFR and colorectal carcinoma: In patients with metastatic CRC (mCRC), two signaling pathways—the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) pathways—are involved in the proliferation and metastasis of CRC [11].